CYP2C9*3 allelic variant and bleeding complications

This publication has 4 references indexed in Scilit:

• Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
  The Lancet, 1999
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
  The Lancet, 1998
• Genetic association between sensitivity to warfarin and expression of CYP2C9*3
  Pharmacogenetics, 1997
• Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study
  European Heart Journal, 1988